The Life Sciences team advised Precision Healing on its acquisition by Sanara MedTech.
Precision Healing develops, markets, and distributes advanced wound care and diagnostic products for use by physicians and clinicians in hospitals, clinics, and post-acute care setting.
Sanara MedTech is a provider of products and technologies for surgical and chronic wound care.
The purchase price for this transaction consists of approximately $5.1 million in stock and cash consideration, the assumption of outstanding options and warrants of Precision Healing and certain earnout obligations, valuing Precision Healing’s equity (excluding shares of Precision Healing held by Sanara and net of the exercise price of options and warrants assumed by Sanara) at approximately $7.8 million before the earnout consideration.
The Goodwin team was led by Michael Bison and Tim Ayotte.
For more details, read the press release and articles in Yahoo Finance and MassDevice.